Price (delayed)
$12.9
Market cap
$1.1B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.66
Enterprise value
$1.05B
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT technology. The Company operates through two subsidiaries, ...
Highlights
LQDA's equity has surged by 63% year-on-year but it is down by 30% since the previous quarter
The company's debt has surged by 147% YoY and by 6% QoQ
LQDA's net income has plunged by 66% YoY and by 9% from the previous quarter
Key stats
What are the main financial stats of LQDA
MarketValuationsEarnings
Shares outstanding
85.3M
Market cap
$1.1B
Enterprise value
$1.05B
Price to earnings (P/E)
N/A
Price to book (P/B)
14.13
Price to sales (P/S)
72.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
74.75
Revenue
$14M
Gross profit
$8.12M
Operating income
-$121.29M
Net income
-$130.39M
EBIT
-$117.91M
EBITDA
-$115.24M
Free cash flow
-$98.36M
Per shareBalance sheetLiquidity
EPS
-$1.66
EPS diluted
-$1.66
Free cash flow per share
-$1.25
Book value per share
$0.91
Revenue per share
$0.18
TBVPS
$2.84
Total assets
$230.31M
Total liabilities
$153.04M
Debt
$122.39M
Equity
$77.28M
Working capital
$143.32M
Debt to equity
1.58
Current ratio
4.43
Quick ratio
4.29
Net debt/EBITDA
0.47
MarginsEfficiencyDividend
EBITDA margin
-823.4%
Gross margin
58%
Net margin
-931.7%
Operating margin
-866.6%
Return on assets
-60.8%
Return on equity
-154.9%
Return on invested capital
-104.8%
Return on capital employed
-62.5%
Return on sales
-842.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LQDA stock price
How has the Liquidia stock price performed over time
Intraday
-8.7%
1 week
-14.51%
1 month
-15.1%
1 year
-15.69%
YTD
9.69%
QTD
-12.54%
Financial performance
How have Liquidia's revenue and profit performed over time
Revenue
$14M
Gross profit
$8.12M
Operating income
-$121.29M
Net income
-$130.39M
Gross margin
58%
Net margin
-931.7%
LQDA financials
The company's net margin has shrunk by 108% YoY and by 22% QoQ
The company's operating margin has shrunk by 107% YoY and by 21% QoQ
LQDA's net income has plunged by 66% YoY and by 9% from the previous quarter
LQDA's operating income has dropped by 65% year-on-year and by 9% since the previous quarter
Growth
What is Liquidia's growth rate over time
LQDA growth chart
Valuation
What is Liquidia stock price valuation
P/E
N/A
P/B
14.13
P/S
72.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
74.75
Price to earnings (P/E)
Liquidia's EPS has decreased by 37% YoY
Price to book (P/B)
The stock's P/B is 86% above its 5-year quarterly average of 7.6 and 19% above its last 4 quarters average of 11.9
LQDA's equity has surged by 63% year-on-year but it is down by 30% since the previous quarter
Price to sales (P/S)
The stock's price to sales (P/S) is 80% more than its 5-year quarterly average of 40.4 and 17% more than its last 4 quarters average of 61.9
LQDA's revenue is down by 20% YoY and by 10% QoQ
Efficiency
How efficient is Liquidia business performance
Liquidia's return on sales has shrunk by 104% YoY and by 20% QoQ
The ROIC has grown by 19% YoY and by 9% from the previous quarter
The ROE has contracted by 17% YoY
The ROA has grown by 7% YoY and by 5% from the previous quarter
Dividends
What is LQDA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LQDA.
Financial health
How did Liquidia financials performed over time
Assets vs liabilities
The total assets is 50% more than the total liabilities
The company's total liabilities has surged by 115% YoY and by 7% QoQ
The total assets has soared by 95% YoY but it has contracted by 9% from the previous quarter
Debt vs equity
The company's debt is 58% higher than its equity
The company's debt has surged by 147% YoY and by 6% QoQ
LQDA's equity has surged by 63% year-on-year but it is down by 30% since the previous quarter
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from 
and Sharadar.